Data / Drug companies / Aromatic Amino Acid
Aromatic Amino Acid drugs: 7 drugs from 52 companies in the FDA NDC directory
Aromatic Amino Acid is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 169 products in this class from 52 companies, covering 7 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on July 13, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 52Companies
- 169Products
- 7Drugs by generic name
Drugs in the Aromatic Amino Acid class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Carbidopa and levodopa | 118 | 41 |
| Carbidopa, levodopa and entacapone | 24 | 4 |
| L-dopa | 4 | 4 |
| Levodopa | 2 | 2 |
| Carbidopa, levodopa, and entacapone | 6 | 1 |
| Carbidopa levodopa | 1 | 1 |
| L dopa | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Deseret Biologicals, Inc. | 10 | liquid; tablet | Unapproved homeopathic products | September 23, 2024 |
| Rising Pharma Holdings, Inc. | 9 | tablet, film coated; tablet, orally disintegrating | Generic drugs (ANDA) | January 8, 2025 |
| Alembic Pharmaceuticals Inc. | 8 | tablet, film coated; tablet, extended release | Generic drugs (ANDA) | February 12, 2026 |
| Alembic Pharmaceuticals Limited | 8 | tablet, film coated; tablet, extended release | Generic drugs (ANDA) | February 12, 2026 |
| Amneal Pharmaceuticals LLC | 8 | capsule, extended release | New drug applications (NDA) | August 9, 2024 |
| A-S Medication Solutions | 7 | tablet | Generic drugs (ANDA) | November 28, 2022 |
| Macleods Pharmaceuticals Limited | 6 | tablet, film coated | Generic drugs (ANDA) | April 15, 2025 |
| Sandoz Inc | 6 | tablet, film coated | Authorized generics (NDA) | June 18, 2014 |
| Advagen Pharma Ltd | 5 | tablet; tablet, extended release | Generic drugs (ANDA) | June 4, 2024 |
| Coupler LLC | 5 | tablet | Generic drugs (ANDA) | July 13, 2026 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 5 | tablet; tablet, extended release | Generic drugs (ANDA) | May 1, 2024 |
| Remedyrepack Inc. | 5 | capsule, extended release; tablet | Authorized generics (NDA) | April 24, 2026 |
| ScieGen Pharmaceuticals, Inc. | 5 | tablet; tablet, extended release | Generic drugs (ANDA) | October 5, 2021 |
| Sun Pharmaceutical Industries, Inc. | 5 | tablet; tablet, extended release | Generic drugs (ANDA) | August 12, 2021 |
| Zydus Pharmaceuticals USA Inc. | 4 | capsule, extended release | Authorized generics (NDA) | October 20, 2025 |
| Aurobindo Pharma Limited | 3 | tablet | Generic drugs (ANDA) | November 28, 2022 |
| AvKARE | 3 | tablet | Generic drugs (ANDA) | February 21, 2024 |
| Camber Pharmaceuticals, Inc. | 3 | tablet | Generic drugs (ANDA) | May 27, 2025 |
| Dr. Reddy's Laboratories Inc. | 3 | tablet | Generic drugs (ANDA) | May 1, 2024 |
| Energique, Inc. | 3 | liquid | Unapproved homeopathic products | January 11, 2022 |
| Proficient Rx LP | 3 | tablet | Generic drugs (ANDA) | September 30, 2021 |
| Sun Pharmaceutical Industries, Inc. | 3 | tablet, orally disintegrating | Generic drugs (ANDA) | December 15, 2014 |
| Teva Pharmaceuticals USA, Inc. | 3 | tablet | Generic drugs (ANDA) | December 15, 2023 |
| TruPharma, LLC | 3 | tablet | Generic drugs (ANDA) | September 21, 2022 |
| Westminster Pharmaceuticals, LLC | 3 | tablet | Generic drugs (ANDA) | September 30, 2021 |
| XLCare Pharmaceuticals, Inc. | 3 | tablet | Generic drugs (ANDA) | January 19, 2026 |
| Accord Healthcare Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | June 13, 2013 |
| American Health Packaging | 2 | tablet | Generic drugs (ANDA) | March 16, 2024 |
| Amneal Pharmaceuticals NY LLC | 2 | tablet, extended release | Generic drugs (ANDA) | December 21, 2022 |
| Aphena Pharma Solutions - Tennessee, LLC | 2 | tablet | Generic drugs (ANDA) | March 15, 2022 |
| BioActive Nutritional, Inc. | 2 | liquid | Unapproved homeopathic products | March 27, 2015 |
| Bryant Ranch Prepack | 2 | tablet, extended release | Generic drugs (ANDA) | October 5, 2021 |
| Bryant Ranch Prepack | 2 | tablet | Generic drugs (ANDA) | November 28, 2022 |
| Cardinal Health 107, LLC | 2 | tablet | Generic drugs (ANDA) | October 10, 2025 |
| Major Pharmaceuticals | 2 | tablet | Generic drugs (ANDA) | April 28, 2025 |
| Mylan Institutional Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | February 1, 2002 |
| Mylan Pharmaceuticals Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | April 26, 2000 |
| Organon LLC | 2 | tablet | New drug applications (NDA) | February 28, 2025 |
| Radha Pharmaceuticals, Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | April 25, 2025 |
| Safecor Health, LLC | 2 | tablet, extended release | Generic drugs (ANDA) | March 13, 2026 |
| AbbVie Inc. | 1 | suspension | New drug applications (NDA) | January 15, 2015 |
| American Health Packaging | 1 | tablet | Generic drugs (ANDA) | July 28, 2025 |
| Aphena Pharma Solutions - Tennessee, LLC | 1 | tablet | Generic drugs (ANDA) | January 19, 2026 |
| AvPAK | 1 | tablet | Generic drugs (ANDA) | June 23, 2026 |
| Avion Pharmaceuticals, LLC | 1 | tablet | New drug applications (NDA) | July 13, 2022 |
| Bryant Ranch Prepack | 1 | tablet | Generic drugs (ANDA) | September 21, 2022 |
| Guangzhou Renuma Medical Systems Co., Ltd | 1 | liquid | Unapproved homeopathic products | October 18, 2017 |
| Merz Pharmaceuticals, LLC | 1 | capsule | New drug applications (NDA) | December 22, 2018 |
| Merz Pharmaceuticals, LLC | 1 | capsule | New drug applications (NDA) | December 22, 2018 |
| NuCare Pharmaceuticals,Inc. | 1 | tablet | Generic drugs (ANDA) | October 28, 2008 |
| Pain and Stress Center Products | 1 | liquid | Unapproved homeopathic products | January 22, 2019 |
| Professional Complementary Health Formulas | 1 | liquid | Unapproved homeopathic products | August 15, 1984 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 72 | 42.6% |
| Tablet, film coated | 30 | 17.8% |
| Tablet, extended release | 26 | 15.4% |
| Capsule, extended release | 16 | 9.5% |
| Liquid | 16 | 9.5% |
| Tablet, orally disintegrating | 6 | 3.6% |
| Capsule | 2 | 1.2% |
| Suspension | 1 | 0.6% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.